Mechanisms, Markers, and Risk Factors in Friedreich’s Ataxia Heart Disease (FA-HD)
|Aug 1 2024
Further Development and Validation of the Cerebellar Neuropsychiatric Rating Scale (CNRS)
|Mar 19 2024
Characterization of the Cardiac Phenotype of Friedreich’s Ataxia
|Mar 19 2024
Call for Patients with Friedreich Ataxia with upcoming surgical procedure or existing tissue
|Mar 19 2024
Biomarkers in Friedreich’s Ataxia
|Mar 19 2024
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants with Friedreich’s Ataxia Aged 2 to 15 Years Old (BRAVE)
|Mar 19 2024
Remote Monitoring Study for Friedreich’s Ataxia
|Mar 19 2024
TRACK-FA: A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich’s ataxia
|Mar 19 2024
Omaveloxolone Dose Finding Study in Children With Friedreich’s Ataxia (BOLD)
|Mar 19 2024
Gene Therapy for Cardiomyopathy Associated with Friedreich’s Ataxia – LX2006
|Mar 19 2024
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia